{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:40:55Z","timestamp":1787884855924,"version":"build-2784847793"},"reference-count":44,"publisher":"Portland Press Ltd.","issue":"2","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":850,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,30]]},"abstract":"<jats:p>The study aims to investigate the effect of vitamin D (VD) combined with pioglitazone hydrochloride (PIO) on bone mineral density (BMD) and bone metabolism in patients with Type 2 diabetic nephropathy (T2DN). T2DN patients were selected and assigned into mild, moderate, and severe groups. In each group, three therapy regimens (VD, PIO, and VD plus PIO) were administered. X-ray absorptiometry was used to measure BMD. Intact parathyroid hormone (iPTH) and 25-hydroxyvitamin D3 (25-OH-VD3) were measured by chemiluminescence meter. ELISA was applied to detect levels of osteoprotegerin (OPG), bone gla protein (BGP), C-terminal telopeptides of type I collagen (\u03b2-CTX), procollagen type I N-propeptide (PINP), pyridinoline (Pyr), and deoxypyridinoline (D-Pyr). Compared with the mild group, T2DN patients in the moderate and severe groups had longer course of disease and higher levels of total cholesterol (TC), triglyceride (TG), serum phosphorus, fasting plasma glucose (FPG), glycosylated hemoglobin (HbAlc) and creatine (Cr), and lower blood calcium. The BMD in different parts increased among the mild, moderate, and severe groups, and the highest BMD was found after VD plus PIO treatment. OPG, iPTH, BGP, \u03b2-CTX, Pyr\/Cr, and D-Pyr\/Cr levels were reduced, while 25-OH-VD3 and PINP levels were elevated among three groups after different treatments, and the most obvious change was observed after VD plus PIO treatment. Our findings indicate that VD combined with PIO may be more effective in improving BMD and bone metabolism than VD or PIO alone in the treatment of T2DN patients, especially for T2DN patients with mild disease.<\/jats:p>","DOI":"10.1042\/bsr20160544","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T01:41:32Z","timestamp":1486086092000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy"],"prefix":"10.1042","volume":"37","author":[{"given":"Ling-Xu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Li","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Women and Infants Hospital of Zhengzhou, Zhengzhou 450012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"2021111619094674500_B1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.hjr.0000368191.86614.5a","article-title":"The global burden of diabetes and its complications: an emerging pandemic","volume":"17","author":"van Dieren","year":"2010","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"2021111619094674500_B2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"2021111619094674500_B3","first-page":"402","article-title":"Concomitant macro and microvascular complications in diabetic nephropathy","volume":"20","author":"Alwakeel","year":"2009","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"2021111619094674500_B4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/ndt\/gfn603","article-title":"Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15)","volume":"24","author":"Yokoyama","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021111619094674500_B5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0272-6386(03)00348-2","article-title":"Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?","volume":"41","author":"Gulati","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"2021111619094674500_B6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1503\/cmaj.071177","article-title":"Diabetes drug pioglitazone (Actos): risk of fracture","volume":"177","author":"Meymeh","year":"2007","journal-title":"Can. Med. Assoc. J."},{"key":"2021111619094674500_B7","doi-asserted-by":"crossref","first-page":"e86773","DOI":"10.1371\/journal.pone.0086773","article-title":"Associations of serum 25-hydroxyvitamin D3 levels with visceral adipose tissue in Chinese men with normal glucose tolerance","volume":"9","author":"Hao","year":"2014","journal-title":"PLoS ONE"},{"key":"2021111619094674500_B8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1139\/h10-109","article-title":"Serum 25OH vitamin D level, femur length, and risk of type 2 diabetes among adults","volume":"36","author":"Liu","year":"2011","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"2021111619094674500_B9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11892-012-0358-4","article-title":"Role of vitamin D in the development of insulin resistance and type 2 diabetes","volume":"13","author":"Pilz","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"2021111619094674500_B10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/toxsci\/kfp256","article-title":"Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat","volume":"113","author":"Suzuki","year":"2010","journal-title":"Toxicol. Sci."},{"key":"2021111619094674500_B11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1995-7645(14)60143-7","article-title":"Protective effect of pioglitazone on kidney injury in diabetic rats","volume":"7","author":"Peng","year":"2014","journal-title":"Asian Pac. J. Trop. Med."},{"key":"2021111619094674500_B12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ando.2012.09.009","article-title":"The relationship between insulin resistance and osteoporosis in elderly male type 2 diabetes mellitus and diabetic nephropathy","volume":"73","author":"Xia","year":"2012","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"2021111619094674500_B13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.2006101112","article-title":"Renal insufficiency and mortality in patients with known or suspected coronary artery disease","volume":"19","author":"van Domburg","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021111619094674500_B14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00774-004-0542-y","article-title":"Osteopenia: a bone disorder associated with diabetes mellitus","volume":"23","author":"Duarte","year":"2005","journal-title":"J. Bone Miner. Metab."},{"key":"2021111619094674500_B15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0974-2727.151681","article-title":"Comparison of bone mineral density, T-scores and serum zinc between diabetic and non diabetic postmenopausal women with osteoporosis","volume":"7","author":"Siddapur","year":"2015","journal-title":"J. Lab. Physicians"},{"key":"2021111619094674500_B16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e318176b40f","article-title":"Bisphosphonates and bone fractures in long-term kidney transplant recipients","volume":"86","author":"Conley","year":"2008","journal-title":"Transplantation"},{"key":"2021111619094674500_B17","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/jcp.24929","article-title":"Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation","volume":"230","author":"Coe","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"2021111619094674500_B18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s00198-016-3585-8","article-title":"The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level","volume":"27","author":"Yun","year":"2016","journal-title":"Osteoporos. Int."},{"key":"2021111619094674500_B19","doi-asserted-by":"crossref","first-page":"145828","DOI":"10.1155\/2015\/145828","article-title":"Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system","volume":"2015","author":"Santoro","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"2021111619094674500_B20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40200-015-0186-6","article-title":"Vitamin D & its analogues in type 2 diabetic nephropathy: a systematic review","volume":"14","author":"Chokhandre","year":"2015","journal-title":"J. Diabetes Metab. Disord."},{"key":"2021111619094674500_B21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1472-6823-14-66","article-title":"Vitamin D supplementation and bone health in adults with diabetic nephropathy: the protocol for a randomized controlled trial","volume":"14","author":"Mager","year":"2014","journal-title":"BMC Endocr. Disord."},{"key":"2021111619094674500_B22","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1136\/annrheumdis-2013-204378","article-title":"Vitamin D receptor regulates TGF-beta signalling in systemic sclerosis","volume":"74","author":"Zerr","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"2021111619094674500_B23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imm.12289","article-title":"1alpha,25-dihydroxyvitamin D3 in combination with transforming growth factor-beta increases the frequency of Foxp3(+) regulatory T cells through preferential expansion and usage of interleukin-2","volume":"143","author":"Chambers","year":"2014","journal-title":"Immunology"},{"key":"2021111619094674500_B24","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.00155.2013","article-title":"Hypoxia-inducible factor-2alpha and TGF-beta signaling interact to promote normoxic glomerular fibrogenesis","volume":"305","author":"Hanna","year":"2013","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"2021111619094674500_B25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2337\/diab.44.10.1139","article-title":"Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator","volume":"44","author":"Sharma","year":"1995","journal-title":"Diabetes"},{"key":"2021111619094674500_B26","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/cbic.201300386","article-title":"A single mutation at the ferredoxin binding site of P450 Vdh enables efficient biocatalytic production of 25-hydroxyvitamin D(3)","volume":"14","author":"Yasutake","year":"2013","journal-title":"ChemBioChem"},{"key":"2021111619094674500_B27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jbmr.2360","article-title":"Femoral volumetric bone density, geometry, and strength in relation to 25-hydroxy vitamin D in older men","volume":"30","author":"Martin","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"2021111619094674500_B28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(13)61647-5","article-title":"Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis","volume":"383","author":"Reid","year":"2014","journal-title":"Lancet"},{"key":"2021111619094674500_B29","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/en.2010-0334","article-title":"Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption","volume":"151","author":"Kogawa","year":"2010","journal-title":"Endocrinology"},{"key":"2021111619094674500_B30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-13-0793","article-title":"The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial","volume":"170","author":"Grey","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"2021111619094674500_B31","first-page":"848243","article-title":"Formulation and evaluation of multilayered tablets of pioglitazone hydrochloride and metformin hydrochloride","volume":"2014","author":"Chowdary","year":"2014","journal-title":"J. Pharm. (Cairo)"},{"key":"2021111619094674500_B32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.5604\/17322693.1080028","article-title":"The role of peroxisome proliferator-activated receptors gamma (PPARgamma) in obesity and insulin resistance","volume":"67","author":"Chmielewska-Kassassir","year":"2013","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"2021111619094674500_B33","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/jc.2007-2249","article-title":"Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"93","author":"Glintborg","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021111619094674500_B34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","article-title":"The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial","volume":"92","author":"Grey","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021111619094674500_B35","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00198-009-1161-1","article-title":"Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus","volume":"21","author":"Kanazawa","year":"2010","journal-title":"Osteoporos. Int."},{"key":"2021111619094674500_B36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5551\/jat.14.86","article-title":"Effects of pioglitazone hydrochloride on Japanese patients with type 2 diabetes mellitus","volume":"14","author":"Teramoto","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"key":"2021111619094674500_B37","first-page":"201","article-title":"Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats","volume":"63","author":"Tsirella","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"2021111619094674500_B38","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db10-1220","article-title":"The RANKL\/RANK\/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy","volume":"60","author":"Ndip","year":"2011","journal-title":"Diabetes"},{"key":"2021111619094674500_B39","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-014-2646-0","article-title":"PINP as a biological response marker during teriparatide treatment for osteoporosis","volume":"25","author":"Krege","year":"2014","journal-title":"Osteoporos. Int."},{"key":"2021111619094674500_B40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/10799893.2014.936463","article-title":"Association of vitamin D receptor BsmI (rs1544410) gene polymorphism with the intact parathyroid hormone (iPTH) level among patients with end-stage renal disease","volume":"35","author":"Zhang","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"2021111619094674500_B41","first-page":"144","article-title":"Correlation of the levels of the bone turnover markers BAP and beta-CTX with bone metastasis progress in lung cancer patients","volume":"16","author":"Tang","year":"2013","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"2021111619094674500_B42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12199-010-0181-y","article-title":"Effect of fluoride exposure on bone metabolism indicators ALP, BALP, and BGP","volume":"16","author":"Song","year":"2011","journal-title":"Environ. Health Prev. Med."},{"key":"2021111619094674500_B43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3346\/jkms.2011.26.8.1093","article-title":"Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old","volume":"26","author":"Je","year":"2011","journal-title":"J. Korean Med. Sci."},{"key":"2021111619094674500_B44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ajh.21856","article-title":"Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis","volume":"85","author":"Nur","year":"2010","journal-title":"Am. J. Hematol."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20160544\/519448\/bsr-2016-0544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20160544\/519448\/bsr-2016-0544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:59:51Z","timestamp":1637092791000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/37\/2\/BSR20160544\/83214\/Effects-of-vitamin-D-combined-with-pioglitazone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20160544","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]},"article-number":"BSR20160544"}}